» Articles » PMID: 18055993

Antithymocyte Globulin and Cyclosporine for Treatment of 44 Children with Hepatitis Associated Aplastic Anemia

Overview
Journal Haematologica
Specialty Hematology
Date 2007 Dec 7
PMID 18055993
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the outcomes of 44 children with hepatitis associated aplastic anemia (HAA) who received immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CsA). Fourteen (31.8%) patients achieved complete response and 17 (38.6%) achieved partial response, for an overall response rate of 70.4% after 6 months. Seven non-responders received bone marrow transplantation from an HLA-matched unrelated donor and 6 out of 7 are alive. The probability of overall survival at 10 years was 88.3+/-4.9%, which supports the role of IST with ATG and CsA as treatment of choice for children with HAA without an HLA identical sibling donor.

Citing Articles

Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period.

Schmutz M, Chartier S, Leblanc T, Mussini C, Gardin A, Gonzales E Front Immunol. 2024; 15:1445610.

PMID: 39328418 PMC: 11425678. DOI: 10.3389/fimmu.2024.1445610.


The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.

Piekarska A, Pawelec K, Szmigielska-Kaplon A, Ussowicz M Front Immunol. 2024; 15:1378432.

PMID: 38646536 PMC: 11026616. DOI: 10.3389/fimmu.2024.1378432.


Clinical characteristics of hepatitis-associated aplastic anemia in children.

Fu L, Zhang J, Wang R, Yang B, Li H, Chen H Ann Hematol. 2023; 103(2):397-404.

PMID: 38082101 DOI: 10.1007/s00277-023-05566-y.


[Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].

Wang Y, Li J, Pang A, Yang D, Chen X, Zhang R Zhonghua Xue Ye Xue Za Zhi. 2023; 44(8):628-634.

PMID: 37803835 PMC: 10520222. DOI: 10.3760/cma.j.issn.0253-2727.2023.08.003.


Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome.

Nastasio S, Mosca A, Alterio T, Sciveres M, Maggiore G Diagnostics (Basel). 2023; 13(17).

PMID: 37685291 PMC: 10486972. DOI: 10.3390/diagnostics13172753.